Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Share News

12345678910

IN BRIEF: PureTech Health loss narrows in "exceedingly strong" half

25th Aug 2022 10:10

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Pretax loss in the first half 2022 narrows to USD56.0 million from USD94.9 million a year before. This is due to a USD28.4 million gain on the dilution of its equity interest in Gelesis Inc. Revenue grows 21% to USD7.0 million from USD5.8 million. Attributes this to increased grant revenue from the Vedanta CARB-X and BARDA grant, as well as Alivio and PureTech LYT Inc. Read More

IN BRIEF: PureTech Health's Sonde Health signs deal for COPD in India

24th Aug 2022 17:58

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says its founded entity, Sonde Health, has signed a multi-year agreement with specialty pharmaceutical company Koye Pharmaceuticals Pvt Ltd. The agreement is to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This is Sonde's first partnership with a pharmaceutical firm, PureTech adds. Read More

TOP NEWS: abrdn indicated to drop out of FTSE 100, F&C to join

23rd Aug 2022 18:14

(Alliance News) - Almost 18 months after announcing a name change, abrdn PLC's blue-chip status is under threat, according to indicative index changes provided by FTSE Russell on Tuesday. Read More

PureTech Health's Akili raises USD163 million via Nasdaq IPO

22nd Aug 2022 09:15

(Alliance News) - PureTech Health PLC said founded entity Akili Inc will start trading on the Nasdaq Capital Market on Monday, after raising funds which will go towards video-game based treatment for children. Read More

PureTech gets USD115 million from sale of Karuna Therapeutics shares

9th Aug 2022 09:31

(Alliance News) - PureTech Health PLC on Tuesday announced it received USD115.4 million after selling a portion of its stake in Karuna Therapeutics Inc. Read More

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

8th Aug 2022 17:06

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears. Read More

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

8th Aug 2022 16:21

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023. Read More

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

1st Aug 2022 21:21

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD. Read More

TRADING UPDATES: BlueRock hit by extreme weather; Harbour drills well

11th Jul 2022 19:15

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: PureTech Health begins pulmonary fibrosis study

30th Jun 2022 21:50

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Begins late-stage clinical study of its wholly-owned candidate LYT-100, or deupirfenidone, in idiopathic pulmonary fibrosis. Will evaluate efficacy of two doses, as well as relative tolerability and efficacy with pirfenidone. IPF is a chronic condition causing progressive scarring of the lungs, which currently has a poor prognosis. Also advances LYT-200 programme through clinical development, and plans to begin leukemia study by the end of 2022. Read More

IN BRIEF: PureTech Health's founded firm Vedanta launches new facility

28th Jun 2022 14:45

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Announces that its founded firm Entity Vedanta Biosciences Inc launches a new manufacturing facility. The facility will "provide clinical and commercial supply of oral therapies" for people infected with a diarrhoea-causing bacteria, firm says. Read More

IN BRIEF: PureTech Health's Gelesis wins USD15 million Plenity order

21st Jun 2022 14:24

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Investee Gelesis Holdings Inc receives another USD15 million pre-order for its weight management aid product Plenity from its distribution partner, New-York based telehealth firm Ro. It brings the total orders from Ro to USD55 million, out of which USD45 million was ordered in the last 12 months, PureTech Health adds. Read More

IN BRIEF: PureTech achieves availability milestone for LYT-300 study

14th Jun 2022 16:54

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Announces results from phase two study of LYT-100-COV on patients with post acute or long Covid with respiratory complications. Read More

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

1st Jun 2022 18:21

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review. Read More

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250

25th May 2022 10:18

(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing television broadcaster ITV PLC and postal operator Royal Mail PLC, according to indicative changes released by FTSE Russell on Tuesday. Read More

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

5th May 2022 12:11

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point. Read More

IN BRIEF: PureTech shares rise as unveils USD50 million share buyback

5th May 2022 11:18

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Approves share buyback of up to USD50 million. Programme follows "follows consultation with shareholders and is consistent with PureTech's capital allocation strategy and stated approach to drive additional value for its shareholders," company says. PureTech says it had USD413.2 million of net cash and cash equivalents at March 31. Given size of balance sheet, PureTech is confident it can return capital to shareholders and also maintain "sufficient cash on hand to deliver" on strategic priorities. Read More

PureTech entity Gelesis reports positive data for weight loss drug

4th May 2022 13:35

(Alliance News) - Boston-based biotechnology company PureTech Health PLC's founded entity Gelesis Holdings Inc said on Wednesday that its weight loss drug showed positive responses in adults in clinical trials. Read More

LONDON BROKER RATINGS: Bank of America cuts Melrose, raises Spectris

27th Apr 2022 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off

26th Apr 2022 18:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

12345678910
FTSE 100 Latest
Value10,364.79
Change188.34